UK-based particle engineering specialist Micropore Technologies has announced a License Agreement with South Korea based G2GBIO Inc. to deploy its patented membrane technology, for the manufacture of G2GBIO’s sustained release pharmaceutical products.   G2GBIO specializes in the development of long-acting microsphere products. Micropore’s membrane-based encapsulation system will complement G2GBIO’s existing InnoLAMP technology for the manufacture of monodisperse microspheres composed of variou...